Ovarian fibrosis in polycystic ovary syndrome: translational perspectives on molecular biomarkers and challenges in non-invasive diagnosis

Main Article Content

Sameer Aymen

Article Details

Section

Infectious Diseases, Immunology and Laboratory Diagnostics

How to Cite

Sameer Aymen. (2026). Ovarian fibrosis in polycystic ovary syndrome: translational perspectives on molecular biomarkers and challenges in non-invasive diagnosis. Partner Conferences of the International Scientific Journal Research Focus, 1(8), 437-438. https://doi.org/10.66073/ReFocus-Conf/3010123

References

Edepli BG, Yaba A. Molecular mechanisms of ovarian fibrosis. Mol Hum Reprod. 2026;32(1):gaaf058. doi:10.1093/molehr/gaaf058. DOI: https://doi.org/10.1093/molehr/gaaf058

He Y, Deng S, Wang Y, et al. Evaluation of ovarian stiffness and its biological mechanism using shear wave elastography in polycystic ovary syndrome. Sci Rep. 2025;15:585. doi:10.1038/s41598-024-84338-8. DOI: https://doi.org/10.1038/s41598-024-84338-8

Nalkande S, Patil M, Nakhate K, Goyal S. Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications. Differentiation. 2026;150:100976. doi:10.1016/j.diff.2026.100976. DOI: https://doi.org/10.1016/j.diff.2026.100976

Gu M, Wang Y, Yu Y. Ovarian fibrosis: molecular mechanisms and potential therapeutic targets. J Ovarian Res. 2024;17(1):139. doi:10.1186/s13048-024-01448-7. DOI: https://doi.org/10.1186/s13048-024-01448-7